Genome-wide association studies (GWAS) and fine-mapping efforts to date have identified
more than 100 prostate cancer (PrCa)-susceptibility loci. We meta-analyzed genotype data …

Prostate cancer is the most frequently diagnosed cancer in males in developed countries.
To identify common prostate cancer susceptibility alleles, we genotyped 211,155 SNPs on a …

Background Radical cystectomy is the surgical standard for invasive bladder cancer. Robot-assisted
cystectomy has been proposed to provide similar oncological outcomes with lower …

Genome-wide association studies (GWAS) have identified 76 variants associated with
prostate cancer risk predominantly in populations of European ancestry. To identify additional …

Prostate cancer is a highly heritable disease with large disparities in incidence rates across
ancestry populations. We conducted a multiancestry meta-analysis of prostate cancer …

Prostate cancers are considered to be immunologically ‘cold’ tumors given the very few
patients who respond to checkpoint inhibitor (CPI) therapy. Recently, enrichment of interferon-…

Context Sexual function is the health-related quality of life (HRQOL) domain most commonly
impaired after prostate cancer treatment; however, validated tools to enable personalized …

Patients with rising prostate-specific antigen (PSA) levels after definitive local therapy of
prostate carcinoma present a diagnostic dilemma. A local recurrence would be amenable to …

Prostate cancer (CaP) is the leading cancer among men of African descent in the USA,
Caribbean, and Sub-Saharan Africa (SSA). The estimated number of CaP deaths in SSA during …

Purpose: The summary presented herein represents Part I of the two-part series dedicated
to Advanced Prostate Cancer: AUA/ASTRO/SUO Guideline discussing prognostic and …